Black Bird Biotech, Inc. BBBT OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score

14/100

0/5 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Black Bird Biotech, Inc. (BBBT) .

Criteria proven by this page:

VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.

Overall SharesGrow Score: 13/100 with 0/7 criteria passed.

SharesGrow 7-Criteria Score

14/100

SG Score

View full scorecard →

—

VALUE

N/A

No coverage

—

FUTURE

N/A

No coverage

✗

PAST

0/100

→ Income

✗

HEALTH

0/100

Debt-to-Equity & liquidity

→ Health

✗

MOAT

0/100

→ Income

GROWTH

58/100

→ Income

✗

INCOME

10/100

→ Income

Valuation Snapshot — BBBT

Valuation Multiples

P/E (TTM)0.0

Forward P/EN/A

PEG RatioN/A

Forward PEGN/A

P/B Ratio0.00

P/S Ratio0.40

EV/EBITDA0.0

Per Share Data

EPS (TTM)$-0.01

Book Value / Share$0.00

Revenue / Share$0.00

FCF / Share$0.00

Yields & Fair Value

Earnings YieldN/A

Dividend Yield0.00%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year	EPS (Diluted)	Revenue	Net Income	Net Margin
2013	$0.00	$0.00	$-89.99K	-
2014	$0.00	$0.00	$-99.52K	-
2015	$0.00	$0.00	$-112.47K	-
2016	$0.00	$0.00	$-106.27K	-
2017	$0.00	$0.00	$-110.01K	-
2018	$0.00	$0.00	$-121.11K	-
2019	$0.00	$17.77K	$-163.63K	-920.8%
2020	$-0.01	$57.6K	$-691.57K	-1200.6%
2021	$-0.01	$104.46K	$-2.1M	-2007.2%
2022	$-0.01	$82.56K	$-1.66M	-2009.1%